Medicare Enrolled

Dr. Jonathan Schwartz, MD

Psychiatry · New Bedford, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
106 SPRING ST, New Bedford, MA 02740
5089976091
In practice since 2005 (20 years)
NPI: 1053393462 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwartz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwartz

Dr. Jonathan Schwartz is a psychiatry specialist in New Bedford, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schwartz performed 4,341 Medicare services across 645 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwartz received a total of $92,773 from 22 pharmaceutical and/or device companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwartz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in MA $92,773 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,341
Medicare services
Top 0% in MA for psychiatry
645
Unique beneficiaries
$141
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~217 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
2,631 $173 $525
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
626 $69 $225
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
374 $98 $255
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
365 $54 $275
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
95 $153 $475
Psychotherapy session, 1 hour
A one-hour psychotherapy session involving talk therapy to address mental health concerns.
78 $118 $300
Magnetic field treatment to stimulate brain nerve cells, initial delivery
A procedure that uses a magnetic field to stimulate nerve cells in the brain. This code covers the initial delivery and management of the treatment.
73 $295 $675
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
41 $70 $325
New patient office visit, complex (60-74 min) 27 $158 $475
Magnetic brain stimulation with motor threshold determination
A procedure using magnetic fields to stimulate nerve cells in the brain. It includes determining the motor threshold and managing the delivery of the treatment.
16 $250 $675
Psychiatric diagnostic evaluation
A clinical assessment conducted by a psychiatrist to evaluate a patient's mental health status and determine a diagnosis.
15 $141 $475
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$92,773
Total received (2018-2024)
Avg $13,253/year across 7 years
Top 2% in MA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
257
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$86,661 (93.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,113 (6.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$87,236
2023
$1,312
2022
$1,463
2021
$392
2020
$477
2019
$906
2018
$987

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neuronetics, Inc.
$86,661
Otsuka America Pharmaceutical, Inc.
$194
ABBVIE INC.
$100
Axsome Therapeutics, Inc.
$95
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$78
Lundbeck LLC
$55
Alkermes, Inc.
$28
Teva Pharmaceuticals USA, Inc.
$15
Corium, LLC
$12
Top 3 companies account for 99.7% of 2024 payments
All-time payments by company (2018-2024) ›
Neuronetics, Inc.
$88,202
Otsuka America Pharmaceutical, Inc.
$815
Sunovion Pharmaceuticals Inc.
$657
Lundbeck LLC
$496
ITI, Inc.
$324
Axsome Therapeutics, Inc.
$320
AbbVie Inc.
$282
ABBVIE INC.
$262
Shire North American Group Inc
$182
Supernus Pharmaceuticals, Inc.
$156
Indivior Inc.
$152
Janssen Pharmaceuticals, Inc
$149
Corium, LLC
$148
Allergan Inc.
$143
Alkermes, Inc.
$124
Vanda Pharmaceuticals Inc.
$108
Ironshore Pharmaceuticals Inc.
$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$78
Teva Pharmaceuticals USA, Inc.
$43
Avion Pharmaceuticals
$22
Takeda Pharmaceuticals U.S.A., Inc.
$14
Allergan, Inc.
$12
Top 3 companies account for 96.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · FANAPT · HETLIOZ · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · MYDAYIS · Methylphenidate Hydrochloride · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · QELBREE · REXULTI · SPRAVATO · SUBLOCADE · TRINTELLIX · Trintellix · UZEDY · VRAYLAR · VYVANSE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 2% for psychiatry in MA.

Looking for a psychiatry specialist in New Bedford?
Compare psychiatrists in the New Bedford area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
110
Per 100K population
19.0
County median income
$84,198
Nearest hospital
SOUTHCOAST BEHAVIORAL HEALTH
4.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schwartz is a clinical cardiology specialist, with above-average Medicare volume (top 0% in MA), with mixed engagement industry engagement in the top 2% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schwartz experienced with magnetic field treatment to stimulate brain nerve cells?
Based on Medicare claims data, Dr. Schwartz performed 2,631 magnetic field treatment to stimulate brain nerve cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwartz receive payments from pharmaceutical companies?
Yes. Dr. Schwartz received a total of $92,773 from 22 companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartz's costs compare to other psychiatrists in New Bedford?
Dr. Schwartz's average Medicare payment per service is $141. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →